We’re a group of creative healthcare leaders with more than 100 years of experience in B2B strategy, growth, marketing, operations, innovation, and investment. We’ve practiced in the provider, health plan, community health, and technology sectors. Throughout our experiences, we came to believe that healthcare in America must transition to a market-based industry to survive. We also encountered many promising businesses designed to thrive in this “smart health market” that weren’t succeeding.
We created Canton & Company to make sure they would.
What We Do
As healthcare growth catalysts, we help providers, vendors, payers, investors, and other organizations develop the fastest path to sustainable success in the evolving value-based landscape. Our comprehensive suite of growth services includes Strategy & Execution, Marketing & Communications, Performance & Business Transformation, and Innovation & Ventures.
We’re not just advisors and consultants, we’re doers. From overall business strategy and growth acceleration, to marketing, operational performance improvement, and innovation, we fill the gaps holding good companies back from being great successes.
Our approach is simple.
Whether it’s a complex corporate pivot, growth strategy, or other arrangement, we implement an easy-to-follow process designed to speed results.
We get to know you and your business
We develop a plan in collaboration with you, to achieve your objectives
We put the plan into action
We measure the progress
We make continuous refinements to ensure your best results
Brent T. Feorene
Chief Transformation Officer
Chief Operating Officer
Chief Financial Officer
Chief Technology Innovation Officer
Chief Marketing Officer
Chief Development Officer
William Streck, MD
Chief Clinical Officer
Most industry experts agree that value-based payment models will define the future of healthcare in part because they reimburse providers for appropriate management of patients, rather than just the volume of patients they serve....
As private equity (PE) firms continue to revise their investment strategies, one pattern seems to be emerging: Many are playing the long game in the healthcare market. And healthcare has some unique features that naturally lend themselves to the long game. For one,...
Despite the global pandemic, 2020 deal activity flourished among private equity (PE) investors in healthcare. The market’s resilience during economic downturns has made it particularly attractive to PE firms, especially those with substantial amounts of dry powder....